1) Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9: 689-701
|
|
|
2) Okeda R, Murayama S, Kuroiwa T, et al. Pathology of the cerebral artery in Binswangerʼs disease in the aged: observation by serial sections and morphometry of the cerebral arteries. Neuropathology. 2004; 24: 21-9
|
|
|
3) Caplan LR, Schoene WC. Clinical features of subcortical arteriosclerotic encephalopathy (Binswanger Disease). Neurology. 1978; 28: 1206-15
|
|
|
4) Arima K, Yanagawa S, Ikeda S, et al. Cerebral arterial pathology of CADASIL and CARASIL (Maeda syndrome). Neuropathology. 2003; 23: 327-34
|
|
|
5) Oide T, Nakayama H, Arima K, et al. Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) Neuropathology. 2008; 28: 132-42
|
|
|
6) Hara K, Shiga A, Onodera O, et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med. 2009; 360: 1729-39
|
|
|
7) 前田 進, 根本清治, 諏訪紀夫, 他. 臨床病理討議会記録. 症例174. 脳の動脈炎による白質の多発性軟化(Binswanger氏病?). 最新医学. 1965; 20: 933- 40
|
|
|
8) Maeda S, Nakayama H, Nemoto S, et al. Familial unusual encephalopathy of Binswangers type without hypertension. Folia Psychiatr Neurol Jpn. 1976; 30: 165-77
|
|
|
9) 根本清治. Encephalitis subcorticalis chronic progressiva (Binswanger) に関する知見補遺. 石橋俊寛教授退官記念論文集, 仙台, 1966. p.51-67
|
|
|
10) 近藤重昭, 小笠原暹, 伊藤智子, 他. 脳髄に限局した壊死性血管炎(periarteritis nodosa?)の一剖検例. 神経進歩. 1970; 14: 274-84
|
|
|
11) 福武敏夫, 服部孝道, 平山恵造, 他. 家族性・若年発症の“Binswanger病様脳症"に頭部びまん性脱毛と腰痛を伴う一症候群について. 臨床神経. 1985; 25: 949-55
|
|
|
12) 福武敏夫, 平山惠造. 家族性若年性Binswanger病様血管性白質脳症. 神経進歩. 1992; 36: 70-80
|
|
|
13) Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nature Genet. 1993; 3: 256-9
|
|
|
14) 西村公孝, 梶山幸司, 北原義介, 他. 若年発症で頭部脱毛, 腰痛, Binswanger病様脳症を呈した1例. 臨床神経. 1985; 25: 496-7
|
|
|
15) Yokoi S, Nakayama H. Chronic progressive leukoencephalopathy with systemic arteriosclerosis in young adults. Clin Neuropathol. 1985; 4: 165-73
|
|
|
16) Yamamura T, Nishimura M, Shirabe T, et al. Subcortical vascular encephalopathy in a normotensive, young adult with premature baldness and spondylitis deformans. A clinicopathological study and review of the literature. J Neurol Sci. 1987; 78: 175-88
|
|
|
17) 高原 晶, 森健一郎, 持永俊一, 他. 頭部びまん性脱毛, 腰痛を伴う若年発症のBinswanger病様脳症の1例. 臨床神経. 1988; 28: 229-30
|
|
|
18) 福島隆三, 佐藤 匡, 木村圭介, 他. 禿頭, 腰痛を伴う若年者ビンスワンガー病様脳症の1孤発例. 臨床神経. 1990; 30: 335
|
|
|
19) 有里敬代, 法化図陽一, 末原雅人, 他. Alopecia, Spondylosis deformansを伴う若年発症Binswanger型脳症の1例. 臨床神経. 1993; 33: 400-4
|
|
|
20) 柳下 章, 中山 宏, 加藤修一, 他. 若年に発症し, 高血圧症を欠き, 禿頭と腰痛を伴う白質脳症. 病理と臨床. 1995; 13: 393-8
|
|
|
21) 岩崎 靖, 加藤武志, 曽根美恵, 他. 頭部び慢性脱毛と変形性脊椎症をともない, 長期にわたって良好な経過を示した若年発症のBinswanger病様白質脳症の1女性例. 神経内科. 1997; 47: 593-600
|
|
|
22) 福武敏夫. Young-adult-onset hereditary subcortical vascular dementia: cerebral autosomal recessive arteriosclerosis with subcortical infarcts and leukoencephalopathy (CARASIL). 臨床神経学. 1999; 39: 50-2
|
|
|
23) 塩田宏嗣, 新保 暁, 田村正人, 他. 高血圧症を欠き, 禿頭と腰痛を伴う若年成人発症Binswanger病様白質脳症(CARASIL)の1女性例. 臨床神経学. 2001; 41: 338
|
|
|
24) 河田浩敏, 滑川道人, 小川朋子, 他. 脳血管病理を検索し得たCARASILの1例. 臨床神経学. 2001; 41: 709
|
|
|
25) Yanagawa S, Ito N, Arima K, et al. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology. 2002; 58: 817-20
|
|
|
26) 中里良彦, 大熊 彩, 溝井令一, 他. 高齢で高血圧を伴わずに白質脳症を発症した若年性禿頭・変形性脊椎症の1例: CARASILの不全型か? 臨床神経. 2008; 48: 406-9
|
|
|
27) Zheng DM, Xu FF, Gao Y, et al. A Chinese pedigree of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): clinical and radiological features. J Clin Neurosci. 2009; 16: 847-9
|
|
|
28) 橋田徳康, 伊藤重雄, 長谷川利英, 他. 視神経炎様症状を呈した遺伝性血管性白質脳症(CARASIL)の1例. 日眼会誌. 2009; 113: 505-12
|
|
|
29) 福武敏夫. CARASIL-脳小血管病の謎に迫る遺伝性疾患-. 分子脳血管病. 2010; 9: 181-9
|
|
|
30) Fukutake T, Hirayama K. Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension. Eur Neurol. 1995; 35: 69-79
|
|
|
31) 内野 誠. CADASIL-脳血管性認知症の病態解明と治療法開発の鍵を握る遺伝性疾患-. 分子脳血管病. 2010; 9: 173-9
|
|
|
32) 吉田光宏, 山田正仁. 脳アミロイドアンギオパチー. 分子脳血管病. 2010; 9: 190-7
|
|
|
33) Richards A, van den Maagdenberg AM, Jen JC, et al. C-terminal truncations in human 3ʼ-5ʼ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet. 2007; 39: 1068-70
|
|
|
34) Plaisier E, Gribouval O, Alamowitch S, et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med. 2007; 357: 2687-95
|
|
|
35) 宇山栄一郎. Fabry病. 脳と神経. 2008; 60: 1235- 44
|
|
|
36) Yokoi S, Nakayama H. Chronic progressive leukoencephalopathy with systemic arteriosclerosis in young adults. Clin Neuropathol. 1985; 4: 165-73
|
|
|
37) Tomimoto H, Ohtani R, Wakita H, et al. Small artery dementiain Japan: radiological differences between CADASIL, leukoaraiosis and Binswangerʼs disease. Dement Geriatr Cogn Disord. 2006; 21: 162-9
|
|
|
38) De Luca A, De Falco M, Severino A, et al. Distribution of the serine protease HtrA1 in normal human tissues. J Histochem Cytochem. 2003; 51: 1279-84
|
|
|
39) Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006; 314: 989-92
|
|
|
40) Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006; 314: 992-3
|
|
|
41) Urano T, Narusawa K, Inoue S, et al. Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women. J Bone Miner Metab. 2010; 28: 220-6
|
|
|
42) Grau S, Baldi A, Ehrmann M, et al. Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci U S A. 2005; 102: 6021-6
|
|
|
43) Bakay M, Zhao P, Chen J, et al. A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul Disord. 2002; 12 (suppl 1): S125-41
|
|
|
44) Grau S, Richards PJ, Kerr B, et al. The role of human HtrA1 in arthritic disease. J Biol Chem. 2006; 281: 6124-9
|
|
|
45) Zumbrunn J, Trueb B. Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett. 1996; 398: 187-92
|
|
|
46) Chien J, Staub J, Hu SI, et al. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene. 2004; 23: 1636-44
|
|
|
47) Baldi A, De Luca A, Morini M, et al. The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells. Oncogene. 2002; 21: 6684-8
|
|
|
48) Esposito V, Campioni M, De Luca A, et al. Analysis of HtrA1 serine protease expression in human lung cancer. Anticancer Res. 2006; 26: 3455-9
|
|
|
49) An E, Sen S, Park KS, et al. Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Invest Ophthalmol Vis Sci. 2010; 51: 3379-86
|
|
|
50) Oka C, Tsujimoto R, Kajikawa M, et al. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development. 2004; 131: 1041-53
|
|
|
51) Goumans MJ, Liu Z, Dijke ten P. TGF-β signaling in vascular biology and dysfunction. Cell Res. 2009; 19: 116-27
|
|
|
52) Pardali E, Goumans MJ, Dijke ten P. Signaling by members of the TGF-β family in vascular morphogenesis and disease. Trends in Cell Biol. 2010; 20: 556-67
|
|
|
53) Feinberg MW, Watanabe M, Lebedeva MA, et al. Transforming growth factor-β1 inhibition of vascular smooth muscle cell activation is mediated via Smad3. J Biol Chem. 2004; 279: 16388-93
|
|
|
54) Liu X, Alexander V, Vijayachandra K, et al. Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci U S A. 2001; 98: 9139-44
|
|
|
55) Yoon BS, Lyons KM. Multiple functions of BMPs in chondrogenesis. J Cell Biochem. 2004; 93: 93-103
|
|
|
56) Charlie ST, Antoine MH. Living beyond our physhiological means - small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke. 2009; 40: e322-30
|
|
|